# NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy

> **NCT04636047** · — · UNKNOWN · sponsor: **Shanghai Chest Hospital** · enrollment: 450 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** The method of gene mutation detection

## Key facts

- **NCT ID:** NCT04636047
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11
- **Primary completion:** 2023-02
- **Final completion:** 2023-08
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2020-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04636047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04636047, "NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04636047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
